6431 — Kuangli Bio Tech Holdings Co Balance Sheet
0.000.00%
- TWD1.56bn
- TWD1.70bn
- TWD381.30m
Annual balance sheet for Kuangli Bio Tech Holdings Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 114 | 183 | 163 | 91 | 42.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 51.8 | 231 | 163 | 136 | 119 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 180 | 523 | 400 | 306 | 249 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 22.3 | 382 | 364 | 381 | 320 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 378 | 1,249 | 1,116 | 1,043 | 910 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 56.3 | 328 | 273 | 283 | 308 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 64.2 | 767 | 443 | 485 | 450 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 314 | 482 | 673 | 558 | 460 |
| Total Liabilities & Shareholders' Equity | 378 | 1,249 | 1,116 | 1,043 | 910 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |